Lymphedema Treatment Market Manufacturers, Suppliers and Exporters of Acute Latest Market Reports

Global Lymphedema Treatment Market Research Report: By Type (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) and By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) – Forecast to 2025

Global Market – Overview

The increasing prevalence of cancer is expected to drive the Global Lymphedema Treatment Market.

The strong clinical pipeline is likely to boost the market growth. Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema—Lymfactin. Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema. The market potential of the drug is estimated to be around USD 650 Million

Key Players

• 3A Health Care (Italy)
• Bio Compression Systems, Inc. (US)
• Devon Medical Products (US)
• HERANTIS PHARMA PLC (Finland)
• Lohmann & Rauscher (Germany)
• Mego Afek Ltd (US)
• SIGVARIS (Switzerland)
• Tactile Systems Technology Inc. (US)
• Wright Therapy Products (BSN Medical) (Germany)

 

Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/8440

Market Influencer

Increased research & development in the market is estimated to influence the commercialization in the market. The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.

Market Drivers

• Increasing cancer cases

Lymphedema is a medical condition characterized by extra fluid buildup in the body tissues, resulting in a blockage of the lymphatic system.

It is reported that a majority of the lymphedema cases affect cancer patients. The condition can arise immediately after cancer surgery or radiation therapy. However, in certain cases, lymphedema is reported after months or years of cancer treatment. Thus, it is projected that the global lymphedema treatment market will grow, parallelly, to the increasing prevalence of cancer.

• Favorable reimbursement policies
• Strong pipeline in the market
• Government support

Market Restraints

• Limited availability of the treatment options available in the market.
• Need to change the compression garments at regular intervals.
• There is a need to change the compression garments at regular intervals. Such garments have a lifespan of approximately six months. This creates reluctance in lymphedema patients to opt for such treatment options, thus, restricting market growth.
• Late diagnosis of lymphedema

Segmentation

By Type

• Primary Lymphedema is caused by the abnormal development of the lymph system. Symptoms may occur at birth or older age. The primary lymphedema segment is estimated to hold the least market share in 2018.
• Secondary Lymphedema is caused by damage to the lymph system owing to cancer treatment involving surgery, radiation therapy, and others. A majority of the patients suffered from secondary lymphedema making this the leading segment in 2018.

 

Access Report Details @  https://www.marketresearchfuture.com/reports/lymphedema-treatment-market-8440

The report for Global market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

By Affected Area

• Lower Extremity: Lower extremity lymphedema involves the swelling of ankles, legs, and feet. This segment is estimated to hold a share of 0% in 2018.
• Upper Extremity: Upper extremity lymphedema is one of the most poorly understood complications of the disease, making the segment to hold a share of 9.0% in the market in 2018.
• Genitalia: This segment held the least share of the market in 2018.

TOC:

1.    Report Prologue    

2.    Market Introduction    

      2.1    Definition    

      2.2    Scope of the Study    

            2.2.1    Research Objective    

            2.2.2    Assumptions    

            2.2.3    Limitations    

3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research    

      3.3    Secondary research

      3.4    Market Size Estimation

TOC…Continued

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/8440

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com